Puerto Rico vs Togo: The number of people with susceptibility test result for rifampicin
Puerto Rico
93.33
in 2021
Togo
92.42
in 2021
Puerto Rico rank
58th
Togo rank
61st
The number of people with susceptibility test result for rifampicin over time
- Puerto Rico
- Togo
How they compare
Puerto Rico currently reports 93.33 against 92.42 in Togo, a difference of 0.91.
Across all 5 years both countries report, Puerto Rico has been ahead every year.
Puerto Rico ranks 58th and Togo ranks 61st of 146 countries.
Puerto Rico has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Puerto Rico | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 97.81 | 36.81 | 61.01 | Puerto Rico |
| 2020s | 94.49 | 90.74 | 3.75 | Puerto Rico |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Puerto Rico or Togo?
- Puerto Rico, at 93.33 against 92.42 in Togo as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Puerto Rico and Togo?
- 0.91, with Puerto Rico ahead.
- How many years of comparable data are there for Puerto Rico and Togo?
- 5 years are reported by both, from 2017 to 2021.
- How do Puerto Rico and Togo rank globally for the number of people with susceptibility test result for rifampicin?
- Puerto Rico ranks 58th and Togo ranks 61st of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.